CD4 and systemic lupus erythematosus: Therefore, patients with SLE treated with hydroxychloroquine had less activation of PBMC-derived T cells than those without, suggesting that hydroxychloroquine reduces the activation of auto-reactive CD4+ T cells (Wu et al., 2017).